Gastroenterology

A new therapeutic target to treat chronic inflammatory disease

Ulcerative Colitis is a chronic and relapsing inflammatory disease. Inflammation plays a major part in the symptoms of this disease that is characterized by pro-inflammatory cytokine production, leukocyte infiltration, and consequent structural and functional damage to the gut. There is still a lot that remains...

Evaluating preclinical emesis induced and nausea by PDE4 inhibitors

Emesis and/or Nausea are commonly reported side effects associated with several drugs such as 4 phosphodiesterase (PDE4) inhibitors and is a major drawback for the therapeutic use of these drugs. The mechanism responsible for this side effect has been investigated in an attempt to discover...

Syncrosome at the next Microbiome & Probotics Forum in Amsterdam

The 4th Microbiome R&D and Business collaboration Forum will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Amsterdam (Netherlands) from 3 to 4th of April. This conference will offer a complete programme focusing on preclinical animal model and specific focuses :Probiotics and Digestive Health (Roles...